What Inflectra treats
Inflectra (infliximab-dyyb) is a biosimilar medication designed to treat various chronic inflammatory conditions, including moderate to severe rheumatoid arthritis (RA), Crohn’s disease, ulcerative colitis, plaque psoriasis, and ankylosing spondylitis. By targeting and inhibiting tumor necrosis factor-alpha (TNF-alpha), Inflectra helps reduce inflammation and alleviate symptoms, providing significant relief for patients with these conditions.
Benefits of Inflectra
Patients using Inflectra often experience significant improvements, including reduced joint pain, better control of gastrointestinal symptoms, clearer skin, and improved mobility. The intravenous administration allows for effective delivery of the medication in a controlled setting, and it is often a more affordable alternative to other TNF inhibitors due to its biosimilar status.
Possible Side Effects of Inflectra
While Inflectra is generally well-tolerated, some patients may experience side effects, including upper respiratory infections, headaches, and nausea. Infusion-related reactions such as fever, chills, or rash can occur, although they are rare. Serious side effects may include an increased risk of infections, allergic reactions, and certain malignancies. It’s important to monitor your health closely and report any unusual symptoms to your healthcare provider.
How infusion works at Prime
Inflectra is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Inflectra, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Inflectra Work?
Inflectra works by blocking TNF-alpha, a protein that plays a central role in the inflammatory process. By neutralizing TNF-alpha, Inflectra effectively reduces inflammation and helps manage symptoms associated with RA, Crohn’s disease, ulcerative colitis, plaque psoriasis, and ankylosing spondylitis. Inflectra is administered through intravenous infusion, with dosing schedules tailored to the specific condition being treated.
Who is Inflectra For?
Inflectra is suitable for adults and children (6 years and older) with moderate to severe RA, Crohn’s disease, ulcerative colitis, plaque psoriasis, or ankylosing spondylitis, especially when other treatments have not provided sufficient relief or are not appropriate. It is also used for patients who have not responded adequately to other TNF inhibitors or biologics.